Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Philip Morris International (PM) through the VizualStocks API.
Historical operating profit from PMI's United States, Canada and Latin America businesses after regional cost of sales and marketing, administration and research costs. The segment included ZYN and other Swedish Match products after the 2022 acquisition and was replaced by the new reporting structure in 2026.
americasOperatingIncomeHistorical net revenue from PMI products sold in the United States, Canada and Latin America, including ZYN nicotine pouches, cigarettes, cigars, snus and other oral tobacco products. The geographic segment was replaced by International Smoke-Free, International Combustibles and U.S. segments in 2026.
americasRevenueNet revenue after excise taxes from products that burn tobacco, principally cigarettes led by Marlboro and PMI's local brands, plus U.S. cigars. This separates PMI's legacy combustible franchise from IQOS, ZYN, VEEV and other smoke-free products.
combustibleProductsRevenueHistorical operating profit from East Asia, Australia and PMI Global Travel Retail after regional cost of sales and marketing, administration and research costs. The region included major IQOS markets such as Japan, was called PMI Duty Free before 2025, and was replaced by PMI's new segment structure in 2026.
eastAsiaAustraliaAndPmiDutyFreeOperatingIncomeHistorical net revenue from East Asia, Australia and PMI Global Travel Retail, including cigarettes and a substantial IQOS heated-tobacco business in markets such as Japan. The unit was called PMI Duty Free before 2025 and was replaced by PMI's new segment structure in 2026.
eastAsiaAustraliaAndPmiDutyFreeRevenueHistorical operating profit from PMI's European cigarette, IQOS, VEEV and other businesses after regional cost of sales and marketing, administration and research costs. The segment included the continuing Aspeya wellness business in 2025 and was replaced by PMI's new segment structure in 2026.
europeOperatingIncomeHistorical net revenue from the European Union, United Kingdom, Switzerland, Ukraine, Moldova and Southeast Europe across cigarettes and smoke-free products such as IQOS and VEEV. In 2025 it also included Aspeya wellness revenue; PMI replaced this geographic segment in 2026.
europeRevenueCans of traditional moist smokeless tobacco shipped by PMI, principally through the Swedish Match portfolio in the United States. Shipment volume is sell-in to distributors and trade customers, so inventory movements can differ from consumer purchases.
moistSnuffShipmentVolumeCansCatalog reconciliation intended to capture operating income not assigned to PMI's named geographic segments. PMI allocated its operating results to disclosed segments, so this is not a separate business; sporadic non-zero values in the series indicate a data-reconciliation defect.
otherOperatingIncomeByGeographyCans or can-equivalents of PMI oral tobacco and nicotine products not classified as nicotine pouches, snus or moist snuff. This is the small residual component used with those three categories to reconcile total oral-product shipment volume.
otherOralProductsShipmentVolumeCansCatalog reconciliation intended for revenue not assigned to a named PMI geographic segment. PMI's disclosed regions already exhaust company revenue, and recent stored values duplicate the combined non-Americas regions, so this is a data defect rather than a real revenue category.
otherRevenueByGeographyLegacy catalog series for net revenue from PMI products that deliver nicotine without burning tobacco, including IQOS heated tobacco, ZYN and other oral nicotine products, and VEEV e-vapor products. PMI now calls this smoke-free product revenue, and the current series requires remapping to the newer disclosure.
reducedRiskProductsRevenuePercentage change in revenue. The calculation reflects the stated excluding foreign exchange and acquisitions adjustment reported by Philip Morris International versus the comparable prior period used in the issuer's disclosure.
revenueGrowthExcludingForeignExchangeAndAcquisitionsHistorical operating profit from PMI's South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa region after cost of sales and marketing, administration and research costs. The grouping included large cigarette markets such as Indonesia, Turkey and Russia and ended with the 2025 reporting year.
southAndSoutheastAsiaCommonwealthOfIndependentStatesMiddleEastAndAfricaOperatingIncomeHistorical net revenue from PMI's South and Southeast Asia, Commonwealth of Independent States, Middle East and Africa region across cigarettes, IQOS and other smoke-free products. The grouping included major markets such as Indonesia, Turkey and Russia and was replaced by product-based international segments in 2026.
southAndSoutheastAsiaCommonwealthOfIndependentStatesMiddleEastAndAfricaRevenueTotal cigarette sticks plus heated-tobacco consumable units shipped by PMI during the period. It measures physical sell-in for the two largest tobacco categories, so growth can differ from revenue because of pricing, product mix, geography and distributor inventories.
totalCigarettesAndHeatedTobaccoShipmentTransactionsUnitsCigarette sticks shipped by PMI during the period across brands such as Marlboro and its local portfolios. This is sell-in volume rather than consumer offtake, and it excludes IQOS heated-tobacco consumables and oral nicotine products.
totalCigarettesShipmentTransactionsUnitsHeated-tobacco consumable units such as HEETS and TEREA shipped for use with PMI's IQOS devices. It tracks adoption of PMI's largest smoke-free platform and excludes the devices themselves, cigarettes, e-vapor and oral nicotine products.
totalHeatedTobaccoShipmentTransactionsUnitsPMI cigarette and heated-tobacco-unit in-market sales as a percentage of estimated industry cigarette and heated-tobacco-unit sales outside the United States and China, including cigarillos in Japan. It measures consumer-channel share rather than factory shipments and combines the shrinking cigarette category with the growing IQOS consumables business.
totalInternationalMarketShareCans of tobacco-leaf-free nicotine pouches shipped globally by PMI, led by ZYN in the United States and international markets. This sell-in measure includes channel-inventory movements and therefore can differ from consumer offtake.
totalNicotinePouchesShipmentVolumeCansCombined cans or can-equivalents of nicotine pouches, snus, moist snuff and other oral products shipped by PMI. It summarizes the oral portfolio acquired largely through Swedish Match, with ZYN nicotine pouches now representing most of the volume.
totalOralProductsShipmentVolumeCansCans of pasteurized oral tobacco pouches shipped by PMI, primarily from the Swedish Match portfolio in Nordic and U.S. markets. Snus contains tobacco leaf and is distinct from tobacco-leaf-free ZYN nicotine pouches.
totalSnusShipmentVolumeCansRevenue from PMI's Aspeya wellness business, focused on oral consumer-wellness products and contract development and manufacturing of oral delivery systems; those services produced most of its 2025 revenue. The revenue was included in Europe in 2025 and in PMI's U.S. segment beginning in 2026.
wellnessAndHealthcareRevenueCans of ZYN tobacco-leaf-free nicotine pouches shipped in the United States during the period. This is sell-in to distributors and trade customers rather than consumer purchases, so wholesaler and distributor inventory changes can materially affect quarterly comparisons.
zynUsShipmentVolumeHistorical operating profit or loss from PMI's former standalone Wellness and Healthcare segment, which included Vectura, Fertin Pharma and related healthcare investments. Standalone reporting ended after the 2024 Vectura sale; continuing Aspeya results moved into Europe in 2025 and the U.S. segment in 2026.
wellnessAndHealthcareOperatingIncome